Pivot

Kane Biotech Announces Private Placement Offering and Proposed Amendments to its Credit Facility

Retrieved on: 
Thursday, August 3, 2023

WINNIPEG, Manitoba, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) today announces its intention to undertake a non-brokered private placement offering (the “Offering”) of up to 6,250,000 units of the Company (“Units”) at a price of $0.08 per Unit for gross proceeds of up to $500,000. Each Unit shall be comprised of one common share of the Company (a “Share”) and one-half of one Share purchase warrant (each whole warrant, a “Warrant”). Each full Warrant shall entitle the holder thereof to purchase one additional Share of the Company for a period of 18 months at an exercise price of $0.10 per Share.

Key Points: 
  • All securities issued in connection with the Offering will be subject to a hold period of four-months and one day in Canada.
  • The Proposed Amended Credit Facility shall have an interest rate of 15% per annum.
  • Under the terms of the Proposed Amended Credit Facility, Pivot and the third party guarantor of $1,000,000 of the Proposed Amended Credit Facility (the “Guarantor”), will each receive 2,500,000 compensation warrants (“Compensation Warrants”).
  • The Proposed Amended Credit Facility is subject to the above-mentioned Offering being fully subscribed, the execution of definitive transaction documents and the receipt of all necessary approvals.

Teva Announces Appointment of Dr. Angus Grant to Executive Vice President, Business Development

Retrieved on: 
Thursday, July 27, 2023

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. Angus Grant, Ph.D., as EVP, Business Development.

Key Points: 
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. Angus Grant, Ph.D., as EVP, Business Development.
  • Most recently, Dr. Grant served as the Chief Business Executive at BeiGene, overseeing business development, clinical and business insights and valuation, investments and collaborations, and alliance management.
  • Earlier in his career, Dr. Grant spent 12 years at Celgene, serving in various leadership roles including Corporate Vice President of Business Development, and Vice President, Regulatory Affairs.
  • Richard Francis, Teva’s President and CEO said: “We are pleased to welcome a leader of Angus caliber to our executive team at Teva.

Digilock Debuts Hardwired Keyless Lock Solution

Retrieved on: 
Tuesday, July 11, 2023

PETALUMA, Calif., July 11, 2023 /PRNewswire/ -- Digilock has announced the launch of Pivot™, hardwired built-in locks for new stationary furniture installations. Recognized as the global leader in storage security, Digilock brings its keyless lock experience to facilities requiring a hardwired power and data source for its permanent fixtures.

Key Points: 
  • Recognized as the global leader in storage security, Digilock brings its keyless lock experience to facilities requiring a hardwired power and data source for its permanent fixtures.
  • The new hardwired solution allows customers to manage Pivot from the same platform as their wire-free Digilock Smart Locks.
  • "Digilock is always looking for innovative ways to serve more customer needs," says Julie Advocate, Executive Vice President of Digilock.
  • "Customers know that if they need a keyless lock solution, Digilock will have the best answer," adds Advocate.

Charlotte County Wins Big with Top State Economic Development Award

Retrieved on: 
Tuesday, June 27, 2023

This recognition, known as a "best in show" award, represents achievement across the state's economic development cities and counties.

Key Points: 
  • This recognition, known as a "best in show" award, represents achievement across the state's economic development cities and counties.
  • On top of the grand prize, Charlotte County also won two additional trophies:
    The county won the Innovation in Marketing award for its PCS to Charlotte County campaign, encouraging veterans and active military families transitioning from the military to choose Charlotte County as their "Permanent Change of Station."
  • Through collaborations with entities across the state, including CareerSource Southwest Florida, the Small Business Administration, Charlotte County Emergency Management, and the United Way of Charlotte County, the Charlotte County EDO navigated crises and persistently supported their community.
  • You can find information about the Charlotte County Economic Development Office on their website, www.Cleared4Takeoff.com , or by contacting Kay Tracy at (941)764-4944 or [email protected] .

Pivotal Commware Lights Up mmWave Fixed Wireless Coverage in Los Angeles

Retrieved on: 
Thursday, June 22, 2023

Pivotal Commware, global leader in 5G mmWave infrastructure products for the wireless edge, announces that Pivotal Turnkey is expanding 5G mmWave coverage for a Tier 1 mobile network operator (MNO) in Los Angeles.

Key Points: 
  • Pivotal Commware, global leader in 5G mmWave infrastructure products for the wireless edge, announces that Pivotal Turnkey is expanding 5G mmWave coverage for a Tier 1 mobile network operator (MNO) in Los Angeles.
  • Pivotal Turnkey provides an end-to-end solution using Pivotal’s mmWave product ecosystem.
  • Turnkey delivers fixed wireless access (FWA) households to MNOs at lower Total Cost of Ownership (TCO) – 25% to 35% the cost of fiber – and lower time-to-revenue.
  • Pivotal’s breakthrough network planning tool, WaveScape™, optimizes the placement of network elements, like the Pivot 5G® network repeater, for a given coverage objective.

Pivotal Commware and MTN Demonstrate mmWave 5G in South Africa

Retrieved on: 
Wednesday, June 21, 2023

Pivotal Commware, a global leader in 5G mmWave infrastructure products for the wireless edge, has concluded a successful 5G mmWave field trial with MTN, Africa’s largest mobile network operator (MNO).

Key Points: 
  • Pivotal Commware, a global leader in 5G mmWave infrastructure products for the wireless edge, has concluded a successful 5G mmWave field trial with MTN, Africa’s largest mobile network operator (MNO).
  • Pivotal products leverage its patented antenna technology, Holographic Beam Forming®.
  • The field trial used Pivotal’s breakthrough network planning tool, WaveScape™, to optimize the placement of multiple Pivot 5G® network repeaters, enhancing mmWave signal coverage for the Festival’s Edge apartment complex in Pretoria.
  • Future testing will include the use of Pivotal’s cloud-based Intelligent Beam Management System (IBMS) to commission, monitor, and optimize Pivot 5G functionality.

SQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy Filing

Retrieved on: 
Friday, June 16, 2023

TORONTO, June 16, 2023 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF) today announced that the Company's board of directors (the "Board") has received a notice of intention (the "Notice") to enforce security issued by its senior secured creditor, Pivot Financial I Limited Partnership ("Pivot"), under Section 244(1) of the Bankruptcy and Insolvency Act (the "Act").

Key Points: 
  • TORONTO, June 16, 2023 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSXV: SQD) (OTCQB: SQIDF) today announced that the Company's board of directors (the "Board") has received a notice of intention (the "Notice") to enforce security issued by its senior secured creditor, Pivot Financial I Limited Partnership ("Pivot"), under Section 244(1) of the Bankruptcy and Insolvency Act (the "Act").
  • As previously announced, there has been significant doubt about the Company's ability to continue as a going concern for several months.
  • As such, while the enforcement of the Notice is subject to a 10-day notice period, the Board has made the decision to consent to the early enforcement of security by Pivot.
  • The Company will proceed with a voluntary assignment in bankruptcy pursuant to the provisions of the Act and upon completion of the filing will announce that such filing is complete and that a trustee has been formally retained.

Kane Biotech Announces First Quarter 2023 Financial Results

Retrieved on: 
Thursday, May 25, 2023

WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced its first quarter 2023 financial results.

Key Points: 
  • WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced its first quarter 2023 financial results.
  • Gross profit for the first quarter of 2023 was $345,047, an increase of 88% compared to $183,621 for the quarter ended March 31, 2022.
  • Detailed financial information about Kane Biotech can be found in its March 31, 2023.
  • Kane Biotech is pleased to invite all interested parties to participate in a conference call on Thursday, May 25, 2023 at 4:30pm ET to review the financial results and discuss business developments in the period.

Teva Launches New “Pivot to Growth” Strategy

Retrieved on: 
Thursday, May 18, 2023

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a new strategic framework with four main pillars to position the Company for a new era of growth.

Key Points: 
  • Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a new strategic framework with four main pillars to position the Company for a new era of growth.
  • This strategy aims to bolster the Company’s strong commercial portfolio with AUSTEDO®, AJOVY®,UZEDYTM and biosimilars, amplify its innovative pipeline, sustain its generics powerhouse and focus the business.
  • “Our new strategy is built on four key pillars to deliver short- and long-term growth from our commercial portfolio and biosimilars, innovative pipeline, generics powerhouse and focused capital allocation,” said Richard Francis, President and CEO, Teva.
  • Teva is additionally well-positioned to capitalize on its late-stage pipeline of biosimilars with 7 products in late-stage development and/or under regulatory review.

Kara Swisher, Angela Zepeda, Grimanesa Amorós Honored with Choose Creativity Award

Retrieved on: 
Tuesday, May 16, 2023

NEW YORK, May 16, 2023 /PRNewswire/ -- Each year Choose Creativity, powered by the Lulu & Leo Fund, selects trailblazers that lead with and inspire creativity within their respective industries and beyond. The 2023 recipients break new ground. The three honorees include Journalist and Media Pioneer Kara Swisher, Chief Marketing Officer of Hyundai Motor America and Creative Storyteller Angela Zepeda, and Acclaimed Multimedia Artist Grimanesa Amorós.

Key Points: 
  • The three honorees include Journalist and Media Pioneer Kara Swisher, Chief Marketing Officer of Hyundai Motor America and Creative Storyteller Angela Zepeda, and Acclaimed Multimedia Artist Grimanesa Amorós.
  • To date, Choose Creativity has reached nearly 1,400 educators and over 24,000 children nationwide.
  • "The only way to describe this year's Choose Creativity Award recipients is relentless pioneers.
  • All proceeds from the Choose Creativity Awards fund the delivery of Choose Creativity's flagship curriculum Learn with Creative Confidence to under-resourced schools and after-school programs.